Literature DB >> 19760078

Causes of death in patients with rheumatoid arthritis from 1971 to 1991 with special reference to autopsy.

Riitta Koivuniemi1, Leena Paimela, Marjatta Leirisalo-Repo.   

Abstract

Rheumatoid arthritis (RA) patients have premature mortality, mostly attributed to cardiovascular diseases (CVDs). We studied causes of death (CoDs) and contribution of autopsy to them in RA patients treated at a single hospital responsible for primary to tertiary RA treatment in Helsinki. In 1971-1991, 960 RA patients died. The leading CoDs were CVDs, RA, and infections. Over 1971-1991, RA and renal deaths declined, but other CoDs showed no change. Autopsied patients died more frequently than nonautopsied of coronary heart disease (CHD) and gastrointestinal disorders, but less frequently of RA, renal, and endocrinologic diseases. Our finding of autopsied patients having CHD more frequently as a CoD may indicate that CHD, which may be asymptomatic in RA, may be overlooked during lifetime.

Entities:  

Mesh:

Year:  2009        PMID: 19760078     DOI: 10.1007/s10067-009-1278-9

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  22 in total

1.  Clinical and autopsy diagnoses in the intensive care unit: a prospective study.

Authors:  Alain Combes; Mourad Mokhtari; Anne Couvelard; Jean-Louis Trouillet; Jérôme Baudot; Dominique Hénin; Claude Gibert; Jean Chastre
Journal:  Arch Intern Med       Date:  2004-02-23

Review 2.  Cardiovascular risk of cyclooxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs.

Authors:  Matthias Hermann; Frank Ruschitzka
Journal:  Ann Med       Date:  2007       Impact factor: 4.709

Review 3.  [Should the use of anti-inflammatory analgesic drugs be estimated again?].

Authors:  J Martio
Journal:  Duodecim       Date:  1993

4.  The autopsy as a measure of accuracy of the death certificate.

Authors:  T Kircher; J Nelson; H Burdo
Journal:  N Engl J Med       Date:  1985-11-14       Impact factor: 91.245

5.  Decreasing mortality in patients with rheumatoid arthritis: results from a large population based cohort in Sweden, 1964-95.

Authors:  Lena Björnådal; Eva Baecklund; Li Yin; Fredrik Granath; Lars Klareskog; Anders Ekbom
Journal:  J Rheumatol       Date:  2002-05       Impact factor: 4.666

Review 6.  Mortality in established rheumatoid arthritis.

Authors:  Sophia M Naz; Deborah P M Symmons
Journal:  Best Pract Res Clin Rheumatol       Date:  2007-10       Impact factor: 4.098

7.  Declines in mortality from acute myocardial infarction in successive incidence and birth cohorts of patients with rheumatoid arthritis.

Authors:  Eswar Krishnan; Vijaya Bharathi Lingala; Gurkirpal Singh
Journal:  Circulation       Date:  2004-09-20       Impact factor: 29.690

8.  Cause of death in rheumatoid arthritis.

Authors:  P Prior; D P Symmons; D L Scott; R Brown; C F Hawkins
Journal:  Br J Rheumatol       Date:  1984-05

9.  Death rates and causes of death in patients with rheumatoid arthritis: a population-based study.

Authors:  S Sihvonen; M Korpela; P Laippala; J Mustonen; A Pasternack
Journal:  Scand J Rheumatol       Date:  2004       Impact factor: 3.641

10.  The widening mortality gap between rheumatoid arthritis patients and the general population.

Authors:  Angel Gonzalez; Hilal Maradit Kremers; Cynthia S Crowson; Paulo J Nicola; John M Davis; Terry M Therneau; Veronique L Roger; Sherine E Gabriel
Journal:  Arthritis Rheum       Date:  2007-11
View more
  7 in total

1.  Mortality in patients with ankylosing spondylitis in Argentina.

Authors:  Emilio Andres Buschiazzo; Emilce Edith Schneeberger; Fernando Andres Sommerfleck; Cesar Ledesma; Gustavo Citera
Journal:  Clin Rheumatol       Date:  2016-07-04       Impact factor: 2.980

2.  Associations of disease activity and treatments with mortality in men with rheumatoid arthritis: results from the VARA registry.

Authors:  Ted R Mikuls; Brian T Fay; Kaleb Michaud; Harlan Sayles; Geoffrey M Thiele; Liron Caplan; Dannette Johnson; John S Richards; Gail S Kerr; Grant W Cannon; Andreas Reimold
Journal:  Rheumatology (Oxford)       Date:  2010-07-21       Impact factor: 7.580

3.  Amino-terminal pro-brain natriuretic peptide as a prognostic marker in patients with rheumatoid arthritis.

Authors:  Bożena Targońska-Stępniak; Maria Majdan
Journal:  Clin Rheumatol       Date:  2010-11-26       Impact factor: 2.980

4.  Targeting interleukin-17 in patients with active rheumatoid arthritis: rationale and clinical potential.

Authors:  Herbert Kellner
Journal:  Ther Adv Musculoskelet Dis       Date:  2013-06       Impact factor: 5.346

Review 5.  Prospects of using cardiovascular magnetic resonance in the identification of arrhythmogenic substrate in autoimmune rheumatic diseases.

Authors:  Sophie I Mavrogeni; Petros P Sfikakis; Theodoros Dimitroulas; Loukia Koutsogeorgopoulou; George Markousis-Mavrogenis; George Poulos; Genovefa Kolovou; George Theodorakis; George D Kitas
Journal:  Rheumatol Int       Date:  2018-07-24       Impact factor: 2.631

6.  Hyposalivation in autoimmune diseases.

Authors:  Etsuko Maeshima; Kanako Furukawa; Shinichiro Maeshima; Hiroya Koshiba; Wataru Sakamoto
Journal:  Rheumatol Int       Date:  2012-12-29       Impact factor: 2.631

7.  Progression of coronary artery atherosclerosis in rheumatoid arthritis: comparison with participants from the Multi-Ethnic Study of Atherosclerosis.

Authors:  Cecilia P Chung; Jon T Giles; Richard A Kronmal; Wendy S Post; Allan C Gelber; Michelle Petri; Moyses Szklo; Robert Detrano; Matthew J Budoff; Roger S Blumenthal; Pamela Ouyang; David Bush; Joan M Bathon
Journal:  Arthritis Res Ther       Date:  2013-09-25       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.